Alector Inc (ALEC)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $382.61M
Last updated: Nov 17, 2026 at 4:15 PM ET
Alector Inc (ALEC) Statistics
Alector (ALEC) has a market cap of $382.61M and an enterprise value of $307.14M. Revenue grew 151.23% over the last 12 months from the 12 months before. Its share count is up 9.03% from a year earlier.
Total Valuation
Enterprise value is 19.73% below the market cap, as cash exceeds debt.
| Market Cap | $382.61M |
|---|---|
| Enterprise Value | $307.14M |
| Latest price (Nov 17, 2026) | $2.56 |
Key Dates
The next earnings report is expected on Feb 23, 2027, covering the quarter ending Dec 31, 2026.
| Next Earnings Date | Feb 23, 2027 (expected) |
|---|---|
| Last Earnings Date | Nov 5, 2026 |
| Fiscal Year End | December |
Valuation Ratios
Sales and book value multiples are 1.7x and 2.5x.
| P/E Ratio | 7.3x |
|---|---|
| P/S Ratio | 1.7x |
| Forward P/S | 1.7x |
| P/B Ratio | 2.5x |
Enterprise Valuation
Counting debt and cash, the company is valued at 4.4x EBITDA.
| EV / Earnings | 7.4x |
|---|---|
| EV / Sales | 1.8x |
| EV / EBITDA | 4.4x |
| EV / EBIT | 7.4x |
Price Statistics
The stock is up 106.45% over 52 weeks and trades 23.67% above its 50-day average.
| Beta (1Y) | 1.66 |
|---|---|
| 52-Week Change | +106.45% |
| 1-Month Change | +31.28% |
| 3-Month Change | +5.35% |
| 6-Month Change | +21.33% |
| 5-Year Change | -89.83% |
| Total Return (1Y) | +106.45% |
| Total Return (3Y CAGR) | -15.94% |
| Total Return (5Y CAGR) | -35.01% |
| Return vs SPY (1Y) | +90.02% |
| Max Drawdown (1Y) | -48.61% |
| Max Drawdown (3Y) | -89.22% |
| Sharpe Ratio (1Y) | 0.86 |
| Correlation with SPY (1Y) | 0.28 |
| 50-Day Average | $2.07 |
| 200-Day Average | $2.06 |
| 52-Week Range | $1.09 to $2.84 |
| RSI (14 Days) | 62.3 |
| Average Volume (20 Days) | 1.97M |
The 5-year change compares month-end closes, adjusted for splits, through Oct 2026.
Financial Position
Current assets cover 4.10x current liabilities, and total debt is 0.00x shareholder equity.
| Current Ratio | 4.10x |
|---|---|
| Quick Ratio | 4.10x |
| Debt / Equity | 0.00x |
Returns and Efficiency
Return on equity is 35.53% and return on assets is 24.98% over the last 12 months.
| Return on Equity (ROE) | 35.53% |
|---|---|
| Return on Assets (ROA) | 24.98% |
| Return on Capital Employed (ROCE) | 32.04% |
| ROA (5Y Average) | -23.30% |
| Asset Turnover | 0.69x |
Taxes
Income tax took 0.86% of pretax income over the last 12 months.
| Income Tax (TTM) | $358.00K |
|---|---|
| Effective Tax Rate | 0.86% |
Scores
ALEC has an Altman Z-Score of -1.38, in the distress zone below 1.81, and a Piotroski F-Score of 1 of 9, in the weak band of 0 to 2.
Altman Z-ScoreDistress below 1.81Safe above 2.99
Piotroski F-ScoreWeak at 2 or lessStrong at 8 or more
| Altman Z-Score | -1.38 |
|---|---|
| Altman Z Zone | Distress |
| Piotroski F-Score | 1 of 9 |
| Piotroski Strength | Weak |
Income Statement
Revenue was $173.47M over the last 12 months.
| Revenue | $173.47M |
|---|---|
| Revenue Growth (YoY) | +151.23% |
| Gross Profit | $173.47M |
| Operating Income | $34.96M |
| Pretax Income | $41.77M |
| Net Income | $41.41M |
| EBITDA | $47.75M |
| EBIT | $41.77M |
| Reported EPS (TTM) | $0.35 |
Trailing 12 months through Sep 30, 2026.
Balance Sheet
Shareholder equity funds 70.32% of the $165.78M in total assets.
| Cash and Equivalents | $75.47M |
|---|---|
| Total Debt | $0 |
| Net Cash | $75.47M |
| Net Cash Per Share | $0.67 |
| Working Capital | $109.93M |
| Shareholder Equity | $116.57M |
| Book Value Per Share | $1.04 |
| Total Assets | $165.78M |
| Total Liabilities | $49.21M |
Balance sheet as of Sep 30, 2026.
Cash Flow
| Operating Cash Flow | -$149.88M |
|---|---|
| FCF Per Share | -$1.34 |
| Depreciation and Amortization | $6.13M |
Trailing 12 months through Sep 30, 2026.
Margins
The operating margin is 20.16%.
| Gross Margin | 100.00% |
|---|---|
| Operating Margin | 20.16% |
| Pretax Margin | 24.08% |
| Net Margin | 23.87% |
| EBITDA Margin | 27.52% |
| EBIT Margin | 24.08% |
Growth
Revenue fell 46.00% a year over 3 years.
| Revenue Growth (3Y CAGR) | -46.00% |
|---|---|
| Revenue Growth (5Y CAGR) | -0.05% |
| Book Value Per Share Growth (2Y CAGR) | -56.90% |
| Tangible Book Per Share Growth (2Y CAGR) | -56.90% |
Dividends and Yields
ALEC does not pay a dividend.
| Earnings Yield | 13.70% |
|---|---|
| Buyback Yield | -1.88% |
| Shareholder Yield | -1.88% |
Peer Position
Against 4 similar companies, ALEC has the lowest P/S.
P/S RatioPeer median 7.9x
Revenue Growth (Trailing 4 Quarters, YoY)Peer median -100.00%
| P/S Ratio | 1.7x vs 7.9x median |
|---|---|
| Revenue Growth (Trailing 4 Quarters, YoY) | +151.23% vs -100.00% median |
Analyst Forecast
Consensus estimates put revenue growth at -8.91% a year over the next 2 fiscal years.
| Revenue Growth Forecast (2Y CAGR) | -8.91% |
|---|
Price Target
Analyst price targets are part of paid GNG plans. See plans
GNG Valuation
| GNG view | Overvalued |
|---|
GNG fair value is part of GNG Pro. See plans
Frequently Asked Questions About ALEC
What is ALEC's market cap?
Alector has a market cap of $382.61M. Its enterprise value, which adds debt and subtracts cash, is $307.14M.
What is ALEC's P/E ratio?
Alector has a trailing P/E ratio of 7.3x.
How many shares of ALEC are outstanding?
Alector has 111.86M shares outstanding. The count is up 9.03% from a year earlier.
Does ALEC pay a dividend?
No. Alector does not pay a dividend.
How much debt does ALEC have?
Alector has $0 of total debt and $75.47M of cash and equivalents, a net cash position of $75.47M.
ALEC pages: Overview, Charting, Earnings, Forecast, Financials, Statistics, Valuation, Competitors